Empresa Elite Pharmaceuticals, Inc. Other OTC
Acciones
ELTP
US28659T2006
Farmacéuticos
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Abbreviated New Drug Applications
100,0
%
| 32 | 100,0 % | 34 | 100,0 % | +5,87 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 32 | 100,0 % | 34 | 100,0 % | +5,87 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 01/08/13 |
Carter Ward
DFI | Director of Finance/CFO | 59 | 01/07/09 |
Christopher Dick
PSD | President | 69 | 01/11/02 |
Douglas Plassche
COO | Chief Operating Officer | 61 | 12/08/13 |
Dianne Will
IRC | Investor Relations Contact | - | 01/01/03 |
Kirko Kirkov
PRN | Corporate Officer/Principal | 56 | 06/09/22 |
George Smith
LAW | General Counsel | - | 20/10/14 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jeffrey Whitnell
BRD | Director/Board Member | 68 | 23/10/09 |
Barry Dash
BRD | Director/Board Member | 93 | 01/04/05 |
Davis Caskey
BRD | Director/Board Member | 76 | 28/04/16 |
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 01/08/13 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 1 017 881 199 | 791 526 006 ( 77,76 %) | 100 000 ( 0,009824 %) | 77,76 % |
Información de la empresa
![Dirección Elite Pharmaceuticals, Inc.(ELTP)](https://cdn.zonebourse.com/static/address/19343831.png)
Sector
Ventas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
+20,76 % | 43,77 mil M | |
+28,00 % | 22,83 mil M | |
+20,25 % | 15,56 mil M | |
+18,82 % | 14,34 mil M | |
+55,83 % | 12,96 mil M | |
-0,05 % | 6787,61 M | |
-12,70 % | 6412,67 M | |
-8,87 % | 5725,52 M | |
+14,65 % | 5686,65 M |